These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 12231217)

  • 1. Arterial enlargement in response to high flow requires early expression of matrix metalloproteinases to degrade extracellular matrix.
    Sho E; Sho M; Singh TM; Nanjo H; Komatsu M; Xu C; Masuda H; Zarins CK
    Exp Mol Pathol; 2002 Oct; 73(2):142-53. PubMed ID: 12231217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent short-duration exposure to low wall shear stress induces intimal thickening in arteries exposed to chronic high shear stress.
    Nanjo H; Sho E; Komatsu M; Sho M; Zarins CK; Masuda H
    Exp Mol Pathol; 2006 Feb; 80(1):38-45. PubMed ID: 15961075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling.
    Berceli SA; Jiang Z; Klingman NV; Pfahnl CL; Abouhamze ZS; Frase CD; Schultz GS; Ozaki CK
    J Vasc Surg; 2004 May; 39(5):1084-90. PubMed ID: 15111865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of matrix metalloproteinases in blood flow-induced arterial enlargement: interaction with NO.
    Tronc F; Mallat Z; Lehoux S; Wassef M; Esposito B; Tedgui A
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):E120-6. PubMed ID: 11116076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic fibroblast growth factor expression precedes flow-induced arterial enlargement.
    Singh TM; Abe KY; Sasaki T; Zhuang YJ; Masuda H; Zarins CK
    J Surg Res; 1998 Jul; 77(2):165-73. PubMed ID: 9733604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of transforming growth factor-beta 1 by pancreatic stellate cells and its implications for matrix secretion and turnover in chronic pancreatitis.
    Shek FW; Benyon RC; Walker FM; McCrudden PR; Pender SL; Williams EJ; Johnson PA; Johnson CD; Bateman AC; Fine DR; Iredale JP
    Am J Pathol; 2002 May; 160(5):1787-98. PubMed ID: 12000730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coordinated elevation of membrane type 1-matrix metalloproteinase and matrix metalloproteinase-2 expression in rat uterus during postpartum involution.
    Manase K; Endo T; Chida M; Nagasawa K; Honnma H; Yamazaki K; Kitajima Y; Goto T; Kanaya M; Hayashi T; Mitaka T; Saito T
    Reprod Biol Endocrinol; 2006 Jun; 4():32. PubMed ID: 16740171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remodeling of carotid artery is associated with increased expression of matrix metalloproteinases in mouse blood flow cessation model.
    Godin D; Ivan E; Johnson C; Magid R; Galis ZS
    Circulation; 2000 Dec; 102(23):2861-6. PubMed ID: 11104745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of matrix metalloproteinases (MMPs) and their tissue inhibitors in human myometrial smooth muscle cells by TGF-beta1.
    Ma C; Chegini N
    Mol Hum Reprod; 1999 Oct; 5(10):950-4. PubMed ID: 10508223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover.
    Phillips PA; McCarroll JA; Park S; Wu MJ; Pirola R; Korsten M; Wilson JS; Apte MV
    Gut; 2003 Feb; 52(2):275-82. PubMed ID: 12524413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of MMPs in the outward remodeling of collateral mesenteric arteries.
    Haas TL; Doyle JL; Distasi MR; Norton LE; Sheridan KM; Unthank JL
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2429-37. PubMed ID: 17644578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of metalloproteinases and their inhibitors in blood vessels in human endometrium.
    Freitas S; Meduri G; Le Nestour E; Bausero P; Perrot-Applanat M
    Biol Reprod; 1999 Oct; 61(4):1070-82. PubMed ID: 10491646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
    Bolbrinker J; Markovic S; Wehland M; Melenhorst WB; van Goor H; Kreutz R
    J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells.
    Zhong J; Gencay MM; Bubendorf L; Burgess JK; Parson H; Robinson BW; Tamm M; Black JL; Roth M
    J Cell Physiol; 2006 May; 207(2):540-52. PubMed ID: 16447244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation between MMP-2 activation and MT1-MMP mRNA expression in thymic epithelial tumors].
    Wang Y; Ueda Y; Shimasaki M; Liu N; Wang EH
    Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):18-23. PubMed ID: 16608644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularization.
    Ma DH; Chen JK; Kim WS; Hao YX; Wu HC; Tsai RJ; Hwang DG; Zhang F
    Ophthalmic Res; 2001; 33(6):353-62. PubMed ID: 11721189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
    Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G
    Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.